Clinical trial
Antimicrobial Resistance in Sputum Obtained From Patients With Cystic Fibrosis (CF)
NCT00360503 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antimicrobial Resistance in Sputum Obtained From Patients With Cystic Fibrosis (CF)
- Lead sponsor
- Seattle Children's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2006
- Completion date
- June 30, 2008
- Enrollment
- 304 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.